DaVita Profile

71.85
USD 0.08  0.11%
96%
89%

DaVita exotic insider transaction detected

DaVita insider trading alert for general transaction of common stock by Kent Thiry, Chairman & Chief Exec. Officer, on July 15, 2018. This event was filed by Davita Inc with SEC on 2007-08-23. Statement of changes in beneficial ownership - SEC Form 4. Kent Thiry is currently serves as chairman, ceo and ceo of healthcare partners of DaVita [view details]   

DaVita Summary

DaVita (DVA) is traded on BATS Exchange in USA. It is located in COLORADO U.S.A and employs 74,500 people. DaVita is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 12.52 B. DaVita runs under Healthcare sector within Healthcare Services industry. This company has 174.5 M outstanding shares of which 6.66 M shares are currently shorted by investors with about 4.38 days to cover shorted positions. DAVITA INC has about 363.48 M in cash with (4.76 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.08.
Check DaVita Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 71.85HorizonTargetOdds Above 71.85
72.93%30 days 71.85 26.57%
Based on normal probability distribution, the odds of DaVita to move above current price in 30 days from now is about 26.57% (This DaVita probability density function shows the probability of DaVita Stock to fall within a particular range of prices over 30 days) .

Top Holders

Selected DaVita Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

DaVita Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for DaVita are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease . DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado. DaVita operates under Medical Care classification in USA and traded on New York Stock Exchange. It employs 74500 people. more
Fama & French Healthcare
Healthcare
Fama & French Classification
DaVita SEC Filings
DaVita SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameDaVita
CEO of Kidney Care DivisionJavier RodriguezView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Medical Care
InstrumentUSA Stock View All
RegionNorth America
LocationCOLORADO U.S.A
Business Address2000 16th Street
ExchangeBATS Exchange
CIK Number0000927066
ISINUS23918K1088
CUSIP89151A107
SectorHealthcare
IndustryHealthcare Services
BenchmarkDOW
Websitewww.davita.com
Phone303 405 2100
CurrencyUSD - US Dollar

DaVita Corporate Directors

Paul Diaz Independent Director
John Nehra Independent Director
Peter Grauer Lead Independent Director
Additionally see Investing Opportunities. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.